Location: Innsbruck
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Innsbruck
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery NA · Medical University of Innsbruck · Medical University Innsbruck · NCT05931783 Austrian PBC Registry Phase N/A · Medizinische Universität Innsbruck · Medical University of Vienna · NCT07598669 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · Medical University Of Innsbruck · Princess Maxima Center for Pediatric Oncology · NCT05327894 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Medizinische Universitaet Innsbruck · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Medizinische Universitaet Innsbruck ( Site 1200) · Merck Sharp & Dohme LLC · NCT06393374 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Universitatsklinikum Innsbruck Universitatsklinik fur Innere · Miltenyi Biomedicine GmbH · NCT04844866 Predication of Arterial Stiffness in Healthy Adults by Oral Health and Chewing Assessments NA · VASCage Study Site · VASCage GmbH · NCT07736222 Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma Phase 3 · Medizinische Universität Innsbruck · Vastra Gotaland Region · NCT06419946 Smartphone Based Digital Screening for Aortic Valve Stenosis Phase N/A · Department of Internal Medicine III · Medical University Innsbruck · NCT07284550 First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve NA · Medical University of Innsbruck · Epygon · NCT04775108 Exercise Intensity and Muscle Recovery in Statin Users NA · University of Innsbruck · Raffaele Mazzolari · NCT07563452 Randomization of Single vs Multiple Arterial Grafts NA · Innsbruck (Medical University) Austria · Weill Medical College of Cornell University · NCT03217006 M-ARS ACL Post-marketing Surveillance Study Phase N/A · Praxis Gelenkpunkt - Sport- und Gelenkchirurgie · Medacta International SA · NCT04462458 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena Phase 3 · Medizinische Universitaet Innsbruck ( Site 0301) · Merck Sharp & Dohme LLC · NCT07216703 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Phase N/A · Innere Medizin 3 - Kardiologie · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine Phase 3 · Medical University of Innsbruck, Merz Investigational Site # · Merz Therapeutics GmbH · NCT07018700 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Phase 3 · Medizinische Universitatsklinik Innsbruck · Janssen Research & Development, LLC · NCT07499232 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child Phase 3 · Kepler Universitätsklinikum GmbH - Klinik für Kinderkardiolo · Bayer · NCT07192952 High Intensity PreHab Before Major Abdominal Surgery NA · Medical University Hospital · Medical University Innsbruck · NCT05355909 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera Phase 3 · Medizinische Universitaet Innsbruck · Eli Lilly and Company · NCT06937086 Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematologi Phase N/A · Medizinische Universität Innsbruck · Medical University Innsbruck · NCT06821880 NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross- NA · Medical University Innsbruck · AUVA · NCT04474106 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures NA · Innsbruck Hospital · AgNovos Healthcare, LLC · NCT04796350 HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011 Phase 2 · Medizinische Universität Innsbruck · Abscint NV/SA · NCT06369831 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes Phase 2 · Medizinische Universität Innsbruck · SAb Biotherapeutics, Inc. · NCT07187531 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes Phase N/A · Local Institution - 0088 · Bristol-Myers Squibb · NCT05489705 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling NA · Universität Klinik für Neurochirurgie · St George's, University of London · NCT04936620 Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosi Phase 3 · Medizinische Universität Innsbruck · Takeda · NCT05677971 HOPE Against Cancer Recurrence in HCC Phase 4 · Medical University of Innsbruck · Philipp Dutkowski · NCT06717919 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer Phase 3 · Medizinische Universitat Innsbruck · Janssen Research & Development, LLC · NCT06319820
Look up another city
Look up another condition
EICHOR